Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LONRF2 pseudogene 4 (LONRF2P4) is a genomic region closely related in sequence to the protein-coding LONRF2 gene. It is annotated as a pseudogene, meaning it does not encode a functional protein product and is not believed to be transcribed for any cellular function[6]. Pseudogenes like LONRF2P4 are remnants of gene duplication or retrotransposition events, often accumulating mutations that prevent protein expression. LONRF2P4 is not a therapeutic target and does not have a characterized role in biology or disease. This is distinct from the functional LONRF2 gene, which encodes a ubiquitin E3 ligase with roles in neuronal protein quality control[1][2][5]. If you are seeking information about the functional protein, refer to "LON peptidase N-terminal domain and ring finger 2" (LONRF2). The entry LONRF2P4 should not be used to represent a druggable, disease-relevant, or functional biological target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on LONRF2 pseudogene 4 (LONRF2P4).